Notícias · Recifes

ADHD medication misuse declines among US adults, study finds

Misuse of stimulant medications for attention-deficit/hyperactivity disorder (ADHD) has declined sharply. In 2023, approximately 3.7% of adults younger than 30 misused these medications, down from 7.5% in 2016. In 2023, 1.9% of adults of all ages misused them, with misuse more co

Admin Recifes 15/07/2026 8

Eight-patient Parkinson's stem cell clinical trial confirms feasibility

A landmark study led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during t

Admin Recifes 15/07/2026 9

The power of conversation post-childbirth: Midwife-led birth debrief strengthens perinatal

A new study from Edith Cowan University (ECU) has found that a structured, midwife-led birth debrief can significantly strengthen women's emotional well-being after childbirth and can be built into routine maternity care.

Admin Recifes 15/07/2026 8

Roupa de academia muito apertada piora celulite?

Roupas apertadas não causam celulite permanente. Elas podem apenas acentuar temporariamente seu aspecto devido à compressão.

Admin Recifes 15/07/2026 8

New approach to gene correction for iron storage disease

Hereditary primary hemochromatosis is caused by a single faulty building block in a gene. This leads to iron overload, which can have serious consequences for organs and joints. In preclinical studies, researchers have already successfully treated this genetic defect using a targ

Admin Recifes 15/07/2026 7

New clinical data advances stem cell-based cell therapy for Parkinson's disease

New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the

Admin Recifes 15/07/2026 8

Long-term stroke data reveal stem cell therapy's safety, biological activity over years

Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.

Admin Recifes 15/07/2026 8

New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant s

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.

Admin Recifes 15/07/2026 10

Data highlight progress toward personalized stem cell therapy for Parkinson's disease

Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea

Admin Recifes 15/07/2026 9

Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now un

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of p

Admin Recifes 15/07/2026 7

Data demonstrate 1-year survival of stem cell-derived neural progenitor cells in patients

New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable

Admin Recifes 15/07/2026 9

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula

Admin Recifes 15/07/2026 9

Acompanhe as Notícias da Recifes